go to contents

Accanis Biotech F

Back to list

Facts

Founded
2015
Staff
8
Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

Profile

What if we could give the body instructions to produce its own drugs? This would be nothing less than a new era in drug therapy and is exactly what messenger RNA (mRNA) could achieve. At ACCANIS, we develop innovative therapeutics for the treatment of common, localized diseases using mRNA. Each cell in your body uses mRNA to translate genetic information into proteins. ACCANIS´ innovative technology takes advantage of this natural mechanism in order to enable effective, on-demand therapeutics.

R&D:ACCANIS is developing optimized, proprietary in vitro transcribed (IVT) mRNA with broad and long-acting therapeutic potential, surpassing protein-based therapeutics.

Similar companies in RDM biotech/pharma

Novartis Pharma GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Sanochemia Pharmazeutika GmbH

Organization type
RDM biotech/pharma
Region
Burgenland
Cluster
LISAvienna
Focus
human health / animal health
Details

Romer Labs Diagnostic GmbH

Organization type
RDM biotech/pharma
Region
Lower Austria
Cluster
ecoplus
Focus
non-specific applications
Details

Viravaxx AG

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Contact

Karl-Farkas-Gasse 22
1030 Wien
Vienna

Contact: Walter Schmidt (CEO)
Email: office@accanis.com
Website